_id
691488b4ccc777a4e85d97e0
Ticker
ORIC
Name
Oric Pharmaceuticals Inc
Exchange
NASDAQ
Address
240 East Grand Avenue, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.oricpharma.com
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Last Close
9.69
Volume
1138765
Current Price
9.38
Change
-3.1991744066047345
Last Updated
2025-12-02T13:09:37.013Z
Image
data:image/webp;base64,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
Ipo Date
2020-04-24T00:00:00.000Z
Market Cap
1085890432
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.37375
Sentiment Sources
4
Rating
4.8333
Target Price
19.9167
Strong Buy
10
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
36671000
Operating Income
-36671000
Interest Expense
-
Pretax Income
-32587000
Net Income
-32587000
Eps
-0.3293168574587954
Dividends Per Share
-
Shares Outstanding
97389279
Income Tax Expense
-
EBITDA
-32299000
Operating Margin
-
Total Other Income Expense Net
4084000
Cash
49668000
Short Term Investments
237472000
Receivables
-
Inventories
-
Total Current Assets
295594000
Property Plant Equipment
2559000
Total Assets
431192000
Payables
2900000
Short Term Debt
3301000
Long Term Debt
-
Total Liabilities
24273000
Equity
406919000
Depreciation
288000
Change In Working Capital
2143000
Cash From Operations
-25112000
Capital Expenditures
35000
Cash From Investing
-110535000
Cash From Financing
109451000
Net Change In Cash
-26196000
PE
-
PB
2.2810000142043014
ROE
-8.008227681676205
ROA
-7.557422215625522
FCF
-25147000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
36671000
Quarters > 0 > income Statement > operating Income
-36671000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-32587000
Quarters > 0 > income Statement > net Income
-32587000
Quarters > 0 > income Statement > eps
-0.3293168574587954
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
98953331
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-32299000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
4084000
Quarters > 0 > balance Sheet > cash
49668000
Quarters > 0 > balance Sheet > short Term Investments
237472000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
295594000
Quarters > 0 > balance Sheet > property Plant Equipment
2559000
Quarters > 0 > balance Sheet > total Assets
431192000
Quarters > 0 > balance Sheet > payables
2900000
Quarters > 0 > balance Sheet > short Term Debt
3301000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
24273000
Quarters > 0 > balance Sheet > equity
406919000
Quarters > 0 > cash Flow > net Income
-32587000
Quarters > 0 > cash Flow > depreciation
288000
Quarters > 0 > cash Flow > change In Working Capital
2143000
Quarters > 0 > cash Flow > cash From Operations
-25112000
Quarters > 0 > cash Flow > capital Expenditures
35000
Quarters > 0 > cash Flow > cash From Investing
-110535000
Quarters > 0 > cash Flow > cash From Financing
109451000
Quarters > 0 > cash Flow > net Change In Cash
-26196000
Quarters > 0 > ratios > PE
-0.3293168574587954
Quarters > 0 > ratios > PB
2.2810000142043014
Quarters > 0 > ratios > ROE
-8.008227681676205
Quarters > 0 > ratios > ROA
-7.557422215625522
Quarters > 0 > ratios > FCF
-25147000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
310000
Quarters > 1 > income Statement > gross Profit
-310000
Quarters > 1 > income Statement > operating Expenses
39064000
Quarters > 1 > income Statement > operating Income
-39064000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-36355000
Quarters > 1 > income Statement > net Income
-36355000
Quarters > 1 > income Statement > eps
-0.4653365129216417
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
78126257
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-38754000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2709000
Quarters > 1 > balance Sheet > cash
75864000
Quarters > 1 > balance Sheet > short Term Investments
206649000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
291124000
Quarters > 1 > balance Sheet > property Plant Equipment
2762000
Quarters > 1 > balance Sheet > total Assets
346857000
Quarters > 1 > balance Sheet > payables
3130000
Quarters > 1 > balance Sheet > short Term Debt
3273000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
22862000
Quarters > 1 > balance Sheet > equity
323995000
Quarters > 1 > cash Flow > net Income
-36355000
Quarters > 1 > cash Flow > depreciation
310000
Quarters > 1 > cash Flow > change In Working Capital
-780000
Quarters > 1 > cash Flow > cash From Operations
-30842000
Quarters > 1 > cash Flow > capital Expenditures
63000
Quarters > 1 > cash Flow > cash From Investing
-76930000
Quarters > 1 > cash Flow > cash From Financing
134302000
Quarters > 1 > cash Flow > net Change In Cash
26530000
Quarters > 1 > ratios > PE
-0.4653365129216417
Quarters > 1 > ratios > PB
2.26183827114616
Quarters > 1 > ratios > ROE
-11.220852173644655
Quarters > 1 > ratios > ROA
-10.481264613370927
Quarters > 1 > ratios > FCF
-30905000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
302000
Quarters > 2 > income Statement > gross Profit
-302000
Quarters > 2 > income Statement > operating Expenses
32718000
Quarters > 2 > income Statement > operating Income
-32718000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-30021000
Quarters > 2 > income Statement > net Income
-30021000
Quarters > 2 > income Statement > eps
-0.42258945520996594
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
71040580
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-32416000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2697000
Quarters > 2 > balance Sheet > cash
49334000
Quarters > 2 > balance Sheet > short Term Investments
154389000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
211433000
Quarters > 2 > balance Sheet > property Plant Equipment
3021000
Quarters > 2 > balance Sheet > total Assets
242858000
Quarters > 2 > balance Sheet > payables
5160000
Quarters > 2 > balance Sheet > short Term Debt
3213000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
23120000
Quarters > 2 > balance Sheet > equity
219738000
Quarters > 2 > cash Flow > net Income
-30021000
Quarters > 2 > cash Flow > depreciation
302000
Quarters > 2 > cash Flow > change In Working Capital
-8486000
Quarters > 2 > cash Flow > cash From Operations
-32775000
Quarters > 2 > cash Flow > capital Expenditures
387000
Quarters > 2 > cash Flow > cash From Investing
22450000
Quarters > 2 > cash Flow > cash From Financing
253000
Quarters > 2 > cash Flow > net Change In Cash
-10072000
Quarters > 2 > ratios > PE
-0.42258945520996594
Quarters > 2 > ratios > PB
3.0325234615769694
Quarters > 2 > ratios > ROE
-13.66217950468285
Quarters > 2 > ratios > ROA
-12.361544606313155
Quarters > 2 > ratios > FCF
-33162000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1066000
Quarters > 3 > income Statement > cost Of Revenue
304000
Quarters > 3 > income Statement > gross Profit
-304000
Quarters > 3 > income Statement > operating Expenses
39266000
Quarters > 3 > income Statement > operating Income
-39570000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-36307000
Quarters > 3 > income Statement > net Income
-36307000
Quarters > 3 > income Statement > eps
-0.5138848627002319
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
70652013
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-36003000
Quarters > 3 > income Statement > operating Margin
-3712.0075046904317
Quarters > 3 > income Statement > total Other Income Expense Net
3263000
Quarters > 3 > balance Sheet > cash
59406000
Quarters > 3 > balance Sheet > short Term Investments
196554000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
262250000
Quarters > 3 > balance Sheet > property Plant Equipment
2924000
Quarters > 3 > balance Sheet > total Assets
274142000
Quarters > 3 > balance Sheet > payables
1548000
Quarters > 3 > balance Sheet > short Term Debt
3183000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
31020000
Quarters > 3 > balance Sheet > equity
243122000
Quarters > 3 > cash Flow > net Income
-36307000
Quarters > 3 > cash Flow > depreciation
304000
Quarters > 3 > cash Flow > change In Working Capital
4380000
Quarters > 3 > cash Flow > cash From Operations
-28054000
Quarters > 3 > cash Flow > capital Expenditures
219000
Quarters > 3 > cash Flow > cash From Investing
42655000
Quarters > 3 > cash Flow > cash From Financing
575000
Quarters > 3 > cash Flow > net Change In Cash
15176000
Quarters > 3 > ratios > PE
-0.5138848627002319
Quarters > 3 > ratios > PB
2.7258573141879388
Quarters > 3 > ratios > ROE
-14.933654708335734
Quarters > 3 > ratios > ROA
-13.243866317455916
Quarters > 3 > ratios > FCF
-28273000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-26.52251407129456
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1107000
Annuals > 0 > income Statement > gross Profit
-1107000
Annuals > 0 > income Statement > operating Expenses
141788000
Annuals > 0 > income Statement > operating Income
-142895000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-127847000
Annuals > 0 > income Statement > net Income
-127847000
Annuals > 0 > income Statement > eps
-1.8335117888180836
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
69727940
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-126740000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
15048000
Annuals > 0 > balance Sheet > cash
59406000
Annuals > 0 > balance Sheet > short Term Investments
196554000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
262250000
Annuals > 0 > balance Sheet > property Plant Equipment
2924000
Annuals > 0 > balance Sheet > total Assets
274142000
Annuals > 0 > balance Sheet > payables
1548000
Annuals > 0 > balance Sheet > short Term Debt
3183000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
31020000
Annuals > 0 > balance Sheet > equity
243122000
Annuals > 0 > cash Flow > net Income
-127847000
Annuals > 0 > cash Flow > depreciation
1107000
Annuals > 0 > cash Flow > change In Working Capital
1968000
Annuals > 0 > cash Flow > cash From Operations
-112662000
Annuals > 0 > cash Flow > capital Expenditures
1188000
Annuals > 0 > cash Flow > cash From Investing
22137000
Annuals > 0 > cash Flow > cash From Financing
126547000
Annuals > 0 > cash Flow > net Change In Cash
36022000
Annuals > 0 > ratios > PE
-1.8335117888180836
Annuals > 0 > ratios > PB
3.197845242306332
Annuals > 0 > ratios > ROE
-52.58553318909848
Annuals > 0 > ratios > ROA
-46.63532038140817
Annuals > 0 > ratios > FCF
-113850000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1032000
Annuals > 1 > income Statement > gross Profit
-1032000
Annuals > 1 > income Statement > operating Expenses
109748000
Annuals > 1 > income Statement > operating Income
-110780000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-100697000
Annuals > 1 > income Statement > net Income
-100697000
Annuals > 1 > income Statement > eps
-1.9571494720553488
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
51450848
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-109748000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
10083000
Annuals > 1 > balance Sheet > cash
23384000
Annuals > 1 > balance Sheet > short Term Investments
184803000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
212597000
Annuals > 1 > balance Sheet > property Plant Equipment
12006000
Annuals > 1 > balance Sheet > total Assets
254686000
Annuals > 1 > balance Sheet > payables
944000
Annuals > 1 > balance Sheet > short Term Debt
2752000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
30598000
Annuals > 1 > balance Sheet > equity
224088000
Annuals > 1 > cash Flow > net Income
-100697000
Annuals > 1 > cash Flow > depreciation
1032000
Annuals > 1 > cash Flow > change In Working Capital
4898000
Annuals > 1 > cash Flow > cash From Operations
-85688000
Annuals > 1 > cash Flow > capital Expenditures
849000
Annuals > 1 > cash Flow > cash From Investing
-43403000
Annuals > 1 > cash Flow > cash From Financing
85658000
Annuals > 1 > cash Flow > net Change In Cash
-43433000
Annuals > 1 > ratios > PE
-1.9571494720553488
Annuals > 1 > ratios > PB
2.560052100960337
Annuals > 1 > ratios > ROE
-44.936364285459284
Annuals > 1 > ratios > ROA
-39.5377052527426
Annuals > 1 > ratios > FCF
-86537000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
966000
Annuals > 2 > income Statement > gross Profit
-966000
Annuals > 2 > income Statement > operating Expenses
91767000
Annuals > 2 > income Statement > operating Income
-91767000
Annuals > 2 > income Statement > interest Expense
2645000
Annuals > 2 > income Statement > pretax Income
-89122000
Annuals > 2 > income Statement > net Income
-89122000
Annuals > 2 > income Statement > eps
-2.247419383960665
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
39655260
Annuals > 2 > income Statement > income Tax Expense
2355000
Annuals > 2 > income Statement > EBITDA
-85801000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2645000
Annuals > 2 > balance Sheet > cash
66840000
Annuals > 2 > balance Sheet > short Term Investments
139432000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
210457000
Annuals > 2 > balance Sheet > property Plant Equipment
14253000
Annuals > 2 > balance Sheet > total Assets
250359000
Annuals > 2 > balance Sheet > payables
1320000
Annuals > 2 > balance Sheet > short Term Debt
2659000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
28008000
Annuals > 2 > balance Sheet > equity
222351000
Annuals > 2 > cash Flow > net Income
-89122000
Annuals > 2 > cash Flow > depreciation
966000
Annuals > 2 > cash Flow > change In Working Capital
-445000
Annuals > 2 > cash Flow > cash From Operations
-75143000
Annuals > 2 > cash Flow > capital Expenditures
2078000
Annuals > 2 > cash Flow > cash From Investing
-109248000
Annuals > 2 > cash Flow > cash From Financing
25225000
Annuals > 2 > cash Flow > net Change In Cash
-159166000
Annuals > 2 > ratios > PE
-2.247419383960665
Annuals > 2 > ratios > PB
1.988550305597906
Annuals > 2 > ratios > ROE
-40.08167267068733
Annuals > 2 > ratios > ROA
-35.5976817290371
Annuals > 2 > ratios > FCF
-77221000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
897000
Annuals > 3 > income Statement > gross Profit
-897000
Annuals > 3 > income Statement > operating Expenses
78871000
Annuals > 3 > income Statement > operating Income
-78871000
Annuals > 3 > income Statement > interest Expense
141000
Annuals > 3 > income Statement > pretax Income
-78715000
Annuals > 3 > income Statement > net Income
-77677000
Annuals > 3 > income Statement > eps
-2.0465939546211915
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37954280
Annuals > 3 > income Statement > income Tax Expense
-1038000
Annuals > 3 > income Statement > EBITDA
-77974000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
156000
Annuals > 3 > balance Sheet > cash
226006000
Annuals > 3 > balance Sheet > short Term Investments
10973000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
240522000
Annuals > 3 > balance Sheet > property Plant Equipment
2413000
Annuals > 3 > balance Sheet > total Assets
298642000
Annuals > 3 > balance Sheet > payables
1886000
Annuals > 3 > balance Sheet > short Term Debt
1926000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
25666000
Annuals > 3 > balance Sheet > equity
272976000
Annuals > 3 > cash Flow > net Income
-78715000
Annuals > 3 > cash Flow > depreciation
897000
Annuals > 3 > cash Flow > change In Working Capital
4073000
Annuals > 3 > cash Flow > cash From Operations
-59541000
Annuals > 3 > cash Flow > capital Expenditures
939000
Annuals > 3 > cash Flow > cash From Investing
158435000
Annuals > 3 > cash Flow > cash From Financing
49134000
Annuals > 3 > cash Flow > net Change In Cash
148028000
Annuals > 3 > ratios > PE
-2.0465939546211915
Annuals > 3 > ratios > PB
1.5502836220033995
Annuals > 3 > ratios > ROE
-28.45561514565383
Annuals > 3 > ratios > ROA
-26.01007226043222
Annuals > 3 > ratios > FCF
-60480000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.3293168574587954
Valuation > metrics > PB
2.2810000142043014
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-8.008227681676205
Profitability > metrics > ROA
-11.024242711286426
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05965069215249227
Risk > metrics > Interest Coverage
-127.32986111111111
Risk > final Score
-449
Risk > verdict
High
Liquidity > metrics > Current Ratio
47.668763102725364
Liquidity > metrics > Quick Ratio
47.668763102725364
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
49.674765384230305
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-5
Prev Risks > 1
5
Prev Risks > 2
-461
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:58:46.963Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.3703
Earnings History > 0 > eps Difference
0.3703
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-13
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.33
Earnings History > 1 > eps Estimate
-0.4
Earnings History > 1 > eps Difference
0.07
Earnings History > 1 > surprise Percent
17.5
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-12
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.47
Earnings History > 2 > eps Estimate
-0.44
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-6.8182
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.42
Earnings History > 3 > eps Estimate
-0.44
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
4.5455
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-10
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.51
Earnings History > 4 > eps Estimate
-0.5084
Earnings History > 4 > eps Difference
-0.0016
Earnings History > 4 > surprise Percent
-0.3147
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.49
Earnings History > 5 > eps Estimate
-0.4717
Earnings History > 5 > eps Difference
-0.0183
Earnings History > 5 > surprise Percent
-3.8796
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-12
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.45
Earnings History > 6 > eps Estimate
-0.41
Earnings History > 6 > eps Difference
-0.04
Earnings History > 6 > surprise Percent
-9.7561
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-06
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.37
Earnings History > 7 > eps Estimate
-0.44
Earnings History > 7 > eps Difference
0.07
Earnings History > 7 > surprise Percent
15.9091
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.49
Earnings History > 8 > eps Estimate
-0.49
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-06
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.44
Earnings History > 9 > eps Estimate
-0.46
Earnings History > 9 > eps Difference
0.02
Earnings History > 9 > surprise Percent
4.3478
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.5
Earnings History > 10 > eps Estimate
-0.57
Earnings History > 10 > eps Difference
0.07
Earnings History > 10 > surprise Percent
12.2807
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.53
Earnings History > 11 > eps Estimate
-0.54
Earnings History > 11 > eps Difference
0.01
Earnings History > 11 > surprise Percent
1.8519
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-16
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.52
Earnings History > 12 > eps Estimate
-0.54
Earnings History > 12 > eps Difference
0.02
Earnings History > 12 > surprise Percent
3.7037
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-07
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.63
Earnings History > 13 > eps Estimate
-0.55
Earnings History > 13 > eps Difference
-0.08
Earnings History > 13 > surprise Percent
-14.5455
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-11
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.51
Earnings History > 14 > eps Estimate
-0.6
Earnings History > 14 > eps Difference
0.09
Earnings History > 14 > surprise Percent
15
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.59
Earnings History > 15 > eps Estimate
-0.57
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-3.5088
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-21
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.58
Earnings History > 16 > eps Estimate
-0.57
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-1.7544
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-08
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.47
Earnings History > 17 > eps Estimate
-0.58
Earnings History > 17 > eps Difference
0.11
Earnings History > 17 > surprise Percent
18.9655
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.57
Earnings History > 18 > eps Estimate
-0.49
Earnings History > 18 > eps Difference
-0.08
Earnings History > 18 > surprise Percent
-16.3265
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-06
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.45
Earnings History > 19 > eps Estimate
-0.48
Earnings History > 19 > eps Difference
0.03
Earnings History > 19 > surprise Percent
6.25
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-23
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.84
Earnings History > 20 > eps Estimate
-0.46
Earnings History > 20 > eps Difference
-0.38
Earnings History > 20 > surprise Percent
-82.6087
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-05
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.41
Earnings History > 21 > eps Estimate
-0.39
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-5.1282
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-05
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.51
Earnings History > 22 > eps Estimate
-0.4
Earnings History > 22 > eps Difference
-0.11
Earnings History > 22 > surprise Percent
-27.5
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-20
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-4.46
Earnings History > 23 > eps Estimate
-0.26
Earnings History > 23 > eps Difference
-4.2
Earnings History > 23 > surprise Percent
-1615.3846
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-02-28
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.08
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.08
Earnings History > 24 > surprise Percent
-
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 and human epidermal growth factor receptor 2 exon 20 with high potency towards exon 20 insertion mutations; and ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study. The company develops ORIC-533, an orally bioavailable small molecule inhibitor of CD73; and ORIC-613, a small molecule therapeutic intended to address a mechanism of innate resistance found in a subset of breast cancers. It has clinical development collaboration agreement for a potential Phase 2 study of ORIC-533 in multiple myeloma with Pfizer Inc.; a clinical trial collaboration and supply agreement with Bayer to evaluate ORIC-944 in combination with Nubeqa AR inhibitor; and a clinical trial collaboration and supply agreement with Johnson & Johnson to evaluate ORIC 944 in combination with Erleada AR inhibitor. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AORIC Pharmaceuticals (ORIC) Surges as Intriguing ESMO Asia Data for Enozertinib Prompts Wells Fargo to Assign Higher Value Yahoo Finance UK
Read more →Frazier Life Sciences Management L.P. Sells 344,859 Shares of Oric Pharmaceuticals, Inc. $ORIC MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$19.9167
Analyst Picks
Strong Buy
10
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 89.34% of the total shares of Oric Pharmaceuticals Inc
1.
Nextech Invest, Ltd.(7.3748%)
since
2025/06/30
2.
VR Adviser, LLC(6.7923%)
since
2025/06/30
3.
Viking Global Investors LP(6.7674%)
since
2025/06/30
4.
Pfizer Inc(5.5356%)
since
2025/06/30
5.
SR ONE CAPITAL MANAGEMENT, LP(4.6487%)
since
2025/06/30
6.
Alkeon Capital Management, LLC(4.6375%)
since
2025/06/30
7.
NEA Management Company, LLC(4.2406%)
since
2025/06/30
8.
BlackRock Inc(4.1988%)
since
2025/06/30
9.
Column Group LLC(3.6457%)
since
2025/06/30
10.
Vivo Capital, LLC(3.2192%)
since
2025/06/30
11.
Vanguard Group Inc(3.2173%)
since
2025/06/30
12.
Point72 Asset Management, L.P.(2.9351%)
since
2025/06/30
13.
T. Rowe Price Associates, Inc.(2.8448%)
since
2025/06/30
14.
FMR Inc(2.5432%)
since
2025/06/30
15.
ACAP Strategic A(2.292%)
since
2025/06/30
16.
First Turn Management LLC(2.0695%)
since
2025/06/30
17.
Vanguard Total Stock Mkt Idx Inv(1.9519%)
since
2025/07/31
18.
SILVERARC CAPITAL MANAGEMENT, LLC(1.8542%)
since
2025/06/30
19.
Balyasny Asset Management LLC(1.8304%)
since
2025/06/30
20.
MPM Oncology Impact Management LP(1.7806%)
since
2025/06/30
21.
State Street Corp(1.6805%)
since
2025/06/30
22.
EcoR1 Capital, LLC(1.666%)
since
2025/06/30
23.
Fidelity Growth Compy Commingled Pl S(1.3491%)
since
2025/07/31
24.
iShares Russell 2000 ETF(1.1277%)
since
2025/08/31
25.
Eventide Healthcare & Life Sciences I(0.9796%)
since
2025/06/30
26.
T. Rowe Price Health Sciences(0.9534%)
since
2025/07/31
27.
US Small-Cap Growth II Equity Comp(0.9412%)
since
2025/06/30
28.
T. Rowe Price New Horizons(0.8034%)
since
2025/07/31
29.
Franklin Biotechnology Discv A(acc)USD(0.7557%)
since
2025/08/31
30.
Fidelity Growth Company Fund(0.7448%)
since
2025/07/31
31.
SPDR® S&P Biotech ETF(0.535%)
since
2025/08/31
32.
Vanguard Institutional Extnd Mkt Idx Tr(0.5109%)
since
2025/07/31
33.
Fidelity Small Cap Index(0.4644%)
since
2025/06/30
34.
Meridian Contrarian Legacy(0.381%)
since
2025/06/30
35.
JPMorgan Small Cap Value I(0.3775%)
since
2025/07/31
36.
Franklin Biotechnology Discovery A(0.374%)
since
2025/07/31
37.
Victory Science & Technology(0.3725%)
since
2025/06/30
38.
Meridian Small Cap Growth Legacy(0.3221%)
since
2025/06/30
39.
ArrowMark Small Cap Gro(0.3221%)
since
2025/06/30
40.
iShares Biotechnology ETF(0.2972%)
since
2025/08/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.3703
Date
2025-09-30
EPS Actual
-0.33
EPS Estimate
-0.4
EPS Difference
0.07
Surprise Percent
17.5%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.